Company / R&D Expense
Colgate-Palmolive R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$366.0M
FY2025
5-year range
$307.0M / $366.0M
FY2021-FY2025
Trend
+3.1%
vs FY2024
Sector context
#7 of 39
Consumer Staples
What the data says
Colgate-Palmolive's r&d expense of $366M is higher than 82% of companies in the Consumer Staples sector (FY2025). R&D Expense has increased for 7 consecutive years, from $277M in FY2018 to $366M in FY2025.
Based on SEC 10-K filings.
$366M in FY2025 with a 5-year CAGR of +4.8%. Top quartile in the Consumer Staples sector.
Improved from $343M to $366M over the past 2 years.
Consumer Staples sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- +4.8%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Consumer StaplesTop 18% of 39This company $366.0M Sector average $203.6M
▼
+79.8% above sector average
Key checks
Key Insights
- Colgate-Palmolive's r&d expense has grown for 7 consecutive years.
- 5-year CAGR of +4.8%, indicating consistent growth.
- In FY2025, r&d expense increased 3.1% year-over-year.
- Ranks #7 out of 39 companies in the Consumer Staples sector.
Company context
Key Data Points
- Altman Z-Score 3.21 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $366.0M | +3.1% |
| FY2024 | $355.0M | +3.5% |
| FY2023 | $343.0M | +7.2% |
| FY2022 | $320.0M | +4.2% |
| FY2021 | $307.0M | +5.9% |
| FY2020 | $290.0M | +3.2% |
| FY2019 | $281.0M | +1.4% |
| FY2018 | $277.0M | -2.8% |
| FY2017 | $285.0M | -1.4% |
| FY2016 | $289.0M | +5.5% |
As of FY2025 · SEC 10-K · Updated Mar 4, 2026